Neovasc (NVC) Tiara Featured In Live Case Session At TCT 2015 Scientific Symposium (Dr. Anson Cheung and Dr. John Webb)

Neovasc Inc. (“Neovasc” or the “Company”)  today announced its Tiara technology was featured in a “live case” broadcast to the 27th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.   TCT is the world's largest educational meeting specializing in interventional cardiovascular medicine and is being held October 10th - 16th, 2015 in San Francisco CA.

In a live case broadcast to the main arena of the conference, Dr. Anson Cheung and Dr. John Webb of St. Paul's Hospital (Vancouver, Canada) successfully implanted a 35mm Tiara transcatheter mitral valve in a patient suffering from severe mitral regurgitation (MR). The implantation was completed successfully, within less than 30 minutes, and without any procedural complications.   Implantation of the Tiara valve resulted in the complete resolution of the patient's MR.

“This live case broadcast reinforced Tiara's potential as a new treatment option for patients with severe MR and who are at high risk for conventional surgery,” commented Neovasc CEO, Alexei Marko. “Attending physicians were able to see first-hand the simplicity of the catheter-based implantation procedure and the resulting elimination of the patient's MR. The TIARA-I Early Feasibility Study is continuing to enroll patients, in the U.S., Canada, and Belgium. We look forward to continuing to expand our Tiara clinical program and ultimately the adoption of Tiara for routine use in these patients, once regulatory approval is obtained.”

Click here to read more